Jerusalem – An ancient Greek drug to treat gout can be used to reduce the risk of death from Covid-19 by nearly 50 per cent, says a new study. The drug Colchicine is derived from the Colchicum family of plants, which was first used for its special healing properties by the ancient Greeks.
Moscow – The Sputnik V vaccine and the one-shot Sputnik Light booster are effective against the vaccine-evading and super mutant Omicron variant of Covid, claimed a laboratory study conducted by Russia’s Gamaleya Center recently.
Ottawa – Health Canada has authorize the use of Pfizer’s COVID-19 antiviral treatment Paxlovid. Pfizer submitted clinical data for the oral medication to treat mild to moderate cases of COVID-19 in adults, on Dec. 1, 2021.
BRUSSELS (Reuters) – The Covax global vaccine-sharing program has delivered 1 billion COVID-19 vaccine doses, one of the organizations which manages it said. Supplies to poorer nations have long been very limited because of lack of vaccines, as wealthier states secured most of the doses initially available from December 2020. But in the last quarter shipments have exponentially increased, allowing …
Washington – The WHO is currently reviewing Merck’s COVID-19 antiviral oral pill molnupiravir and it is thought that a recommendation will likely be made by early February. According to Janet Diaz, WHO lead on clinical management, WHO’S Guidelines Development Group is also getting ready to review Pfizer’s oral pill.
London (Reuters) – AstraZeneca (AZN.L) said that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose.
OTTAWA – Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024. Signed last year, the contracts are to bring up to 65 million doses of Pfizer-BioNTech and 35 million doses of Moderna to Canada this year, and then 60 million Pfizer and 35 …
Washington – Health experts say Molnupiravir – an oral antiviral pill approved for treating Covid-19, says the benefits of the drug outweigh potential risks it may have in the case of high-risk patients. Developed by US-based drug company Merck, Molnupiravir is approved by the US Food and Drug Administration against Covid-19. It is also approved by the UK Medicines and …
Ontario – As the highly transmissible Omicron variant of COVID-19 surges across the country, Canada’s National Advisory Committee on Immunization (NACI) has recommended that moderately or severely immunocompromised Canadians may receive a second booster or fourth shot at least six months after their last dose. “Many of these individuals are at a higher risk of severe outcomes of COVID-19 and …
Washington – Moderna CEO Stephane Bancel has said the efficacy of boosters against Covid-19 will likely decline over time, and a fourth shot will be required to increase their protection. Bancel said people who received their boosters last fall will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape …
World
343,332,219
USA
70,544,862
India
38,566,027
Canada
2,868,822
Pakistan
1,353,479
